Lonsdale alment praktiserende læge(r) ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 1.9% 1.7% 2.5%  
Credit score (0-100)  0 0 69 72 57  
Credit rating  N/A N/A BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.9 2.1 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 3,394 3,399 3,091  
EBITDA  0.0 0.0 1,205 696 260  
EBIT  0.0 0.0 1,087 570 130  
Pre-tax profit (PTP)  0.0 0.0 1,043.4 561.4 121.8  
Net earnings  0.0 0.0 792.7 431.1 87.2  
Pre-tax profit without non-rec. items  0.0 0.0 1,043 561 122  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 232 217 330  
Shareholders equity total  0.0 0.0 833 1,264 1,347  
Interest-bearing liabilities  0.0 0.0 973 729 40.4  
Balance sheet total (assets)  0.0 0.0 2,459 2,374 1,912  

Net Debt  0.0 0.0 -233 -728 -680  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 3,394 3,399 3,091  
Gross profit growth  0.0% 0.0% 0.0% 0.1% -9.1%  
Employees  0 0 3 3 5  
Employee growth %  0.0% 0.0% 0.0% 0.0% 66.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 2,459 2,374 1,912  
Balance sheet change%  0.0% 0.0% 0.0% -3.5% -19.4%  
Added value  0.0 0.0 1,205.0 687.9 260.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 648 -194 -84  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 32.0% 16.8% 4.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 44.2% 23.6% 6.2%  
ROI %  0.0% 0.0% 60.0% 29.8% 7.8%  
ROE %  0.0% 0.0% 95.2% 41.1% 6.7%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 33.9% 53.2% 70.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -19.3% -104.6% -261.0%  
Gearing %  0.0% 0.0% 116.8% 57.7% 3.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 8.9% 1.0% 3.1%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 2.0 3.3 1.9  
Current Ratio  0.0 0.0 2.0 3.3 1.9  
Cash and cash equivalent  0.0 0.0 1,206.2 1,456.9 720.1  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 826.3 1,165.1 478.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 402 229 52  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 402 232 52  
EBIT / employee  0 0 362 190 26  
Net earnings / employee  0 0 264 144 17